American Exceptionalism Acquisition Corp. A Files S-1

TL;DR

AEAC files S-1, get ready for potential SPAC action.

AI Summary

American Exceptionalism Acquisition Corp. A filed an S-1 form on August 18, 2025, detailing its business operations and financial structure. The company is incorporated in Delaware and has its fiscal year end on December 31. Its business address is located at 506 Santa Cruz Ave., Suite 300, Menlo Park, CA 94025, with a contact phone number of 6505219007.

Why It Matters

This S-1 filing provides the initial public disclosure of American Exceptionalism Acquisition Corp. A's business and financial details, crucial for investors considering participation in the company's offerings.

Risk Assessment

Risk Level: medium — As a Special Purpose Acquisition Company (SPAC), its success is contingent on finding and merging with a target company, introducing inherent acquisition risk.

Key Players & Entities

• American Exceptionalism Acquisition Corp. A (company) — Filer of the S-1
• 20250818 (date) — Filing date
• 333-289701 (dollar_amount) — SEC File Number
• 506 SANTA CRUZ AVE. SUITE 300 (location) — Business Address
• MENLO PARK (location) — City of Business Address
• CA (location) — State of Business Address
• 94025 (location) — ZIP Code of Business Address
• 6505219007 (dollar_amount) — Business Phone Number

FAQ

Key Financial Figures

• $250,000,000 — UST 18, 2025 PRELIMINARY PROSPECTUS $250,000,000 American Exceptionalism Acquisition Co
• $0.0001 — our Class A ordinary shares, par value $0.0001 per share, at an initial public offerin
• $10.00 — tial public offering price per share of $10.00. The underwriter has a 45-day option fr
• $1,750,000 — ll), at a price of $10.00 per share, or $1,750,000 in the aggregate (regardless of whether
• $25,000 — on. On July 25, 2025, our sponsor paid $25,000, or approximately $0.002 per share, to
• $0.002 — sponsor paid $25,000, or approximately $0.002 per share, to cover certain of our offe
• $15 — business combination equals or exceeds $15.00, (B) solely with respect to an addit
• $17 — business combination equals or exceeds $17.50, and (C) solely with respect to the
• $20 — business combination equals or exceeds $20.00, and (ii) subsequent to the completi
• $2,000,000 — ng, our sponsor agreed to loan us up to $2,000,000 to be used for a portion of the expense
• $1,500,000 — makes any working capital loans, up to $1,500,000 of such loans may be converted into pri
• $10,000 — es provided to us in an amount fixed at $10,000 per month. In 2025, our sponsor transfe
• $100,000 — on (net of taxes payable and less up to $100,000 of interest to pay liquidation and diss
• $250,000 — 9.69 $ 242,250,000 (1) Includes $250,000 (such amount to remain unchanged in the
• $0.30 — closing of this offering. Also includes $0.30 per share on all shares sold ($7,500,00

Filing Documents

• d38750ds1.htm (S-1) — 2067KB
• d38750dex31.htm (EX-3.1) — 223KB
• d38750dex41.htm (EX-4.1) — 16KB
• d38750dex101.htm (EX-10.1) — 70KB
• d38750dex103.htm (EX-10.3) — 99KB
• d38750dex104.htm (EX-10.4) — 33KB
• d38750dex105.htm (EX-10.5) — 127KB
• d38750dex106.htm (EX-10.6) — 21KB
• d38750dex107.htm (EX-10.7) — 43KB
• d38750dex108.htm (EX-10.8) — 10KB
• d38750dex231.htm (EX-23.1) — 2KB
• d38750dexfilingfees.htm (EX-FILING FEES) — 18KB
• 0001193125-25-182758.txt ( ) — 4264KB
• ck0002079173-20250728.xsd (EX-101.SCH) — 32KB
• d38750ds1_htm.xml (XML) — 193KB
• d38750dexfilingfees_htm.xml (XML) — 5KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations — Related Party Transactions ," " Principal Shareholders — Restrictions on Transfers of Founder Shares and Private Placement Shares ," " Principal Shareholders — Registration Rights ," " Certain Relationships and Related Party Transactions ," and "

Description of Securities

Description of Securities — Private Placement Shares " for more information. On July 25, 2025, our sponsor paid $25,000, or approximately $0.002 per share, to cover certain of our offering costs in exchange for 12,321,429 Class B ordinary shares, par value $0.0001 per share, which we also refer to throughout this prospectus as founder shares. Up to 1,607,143 of the founder shares will be surrendered to us for no consideration after the closing of this offering depending on the extent to which the underwriter's over-allotment option is exercised. The founder shares outstanding following the completion of the offering will only automatically convert into Class A ordinary shares on or prior to the tenth anniversary of our initial business combination, upon the earlier of (i) (A) solely with respect to one-third of such aggregate number of founder shares, a time after the completion of our initial business combination in which the last reported sale price of Class A ordinary shares for any 20 trading days within a 30-trading day period commencing after the completion of the initial business combination equals or exceeds $15.00, (B) solely with respect to an additional one-third of such aggregate number of founder shares, a time after the completion of our initial business combination in which the last reported sale price of Class A ordinary shares for any 20 trading days within a 30-trading day period commencing after the completion of the initial business combination equals or exceeds $17.50, and (C) solely with respect to the remaining one-third of such aggregate number of founder shares, a time after the completion of our initial business combination in which the last reported sale price of Class A ordinary shares for any 20 trading days within a 30-trading day period commencing after the completion of the initial business combination equals or exceeds $20.00, and (ii) subsequent to the completion of our initial business combination, the date on which a change of

Description of Securities

Description of Securities — Founder Shares " for further discussion on our sponsor's and our affiliates' securities. We are not prohibited from paying any fees (including advisory fees, consulting fees or success fees) and reimbursements or cash payments to our sponsor, officers or directors, or our or their affiliates, for services rendered to us prior to or in connection with the completion of our initial business combination, including payment of consulting, legal, success or finder fees to our independent directors, advisors, or their respective Table of Contents affiliates in connection with the consummation of our initial business combination. Prior to the closing of this offering, our sponsor agreed to loan us up to $2,000,000 to be used for a portion of the expenses of this offering. This loan may be repaid by us at any time, and is required to be repaid upon the earlier of December 31, 2027, the completion of our initial business combination or an earlier event of default. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us additional funds as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, no proceeds from our trust account would be used to repay such loaned amounts. Additionally, if the sponsor makes any working capital loans, up to $1,500,000 of such loans may be converted into private placement shares at $10.00 per share, resulting in the sponsor receiving an additional 150,000 private placement Class A ordinary shares, which could materially dilute our public shareholders. Further, we may engage our sponsor or an affiliate of our sponsor as an advisor or otherwise in connection with our initial business combination and cer

Use of Proceeds

Use of Proceeds ," "

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations — Related Party Transactions " and " Certain Relationships and Related Party Transactions " for further discussion on compensation paid or to be paid to our sponsor and its affiliates. As more fully discussed in " Management — Conflicts of Interest ," each of our officers and directors presently has, and any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one or more other entities pursuant to which such officer or director may or may be required to present a business combination opportunity to such entities. The low price that our sponsor, executive officers, and directors (directly or indirectly) paid for the founder shares creates an incentive whereby our officers and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. If we are unable to complete our initial business combination within 24 months from the closing of this offering (or 27 months from the closing of this offering if we have executed a definitive agreement for an initial business combination within 24 months from the closing of this offering), or by such earlier liquidation date as our board of directors may approve, or such later period approved by our shareholders, the founder shares and private placement shares may be worthless, except to the extent they receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. We seek to mitigate this risk through the stock price thresholds applicable to the conversion of the founder shares described above and elsewhere in this prospectus. Further, each of

Risk Factors

Risk Factors " beginning on page 50 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings. Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. No offer or invitation, whether directly or indirectly, is being or may be made to the public in the Cayman Islands to subscribe for any of our securities. Per Share Total Public offering price $ 10.00 $ 250,000,000 Underwriting discounts and commissions (1) $ 0.31 $ 7,750,000 Proceeds, before expenses, to us $ 9.69 $ 242,250,000 (1) Includes $250,000 (such amount to remain unchanged in the event the underwriter's over-allotment option is exercised in full) payable to the underwriter upon the closing of this offering. Also includes $0.30 per share on all shares sold ($7,500,000 in the aggregate (assuming no redemptions) or up to $8,625,000 in the aggregate if the underwriter's over-allotment option is exercised in full (assuming no redemptions)) payable to the underwriter for deferred underwriting commissions to be deposited into a trust account located in the United States and released to Santander US Capital Markets LLC or its own account only upon the completion of an initial business combination. Such deferred underwriting commissions will not be payable with respect to any shares redeemed in connection with an initial business combination and may be paid at the sole and absolute discretion of our management team to any one or more FINRA members, which may or may not include the underwriter. See also " Underwriting " for a description of compensation and other items of value payable to the underwriter. In addition to the underwr

Risk Factors

Risk Factors — Risks Relating to our Securities — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline ." and "

Risk Factors

Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination — We may issue additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the founder shares at a ratio greater than one-to-one as a result of the anti-dilution provisions contained therein. Any such issuances would dilute the interest of our shareholders and likely present other risks. " The following table illustrates the difference between the deemed offering price of $10.00 per share and our net tangible book value per share ("NTBV"), as adjusted to give effect to this offering, including the structure of the underwriting commissions, and assuming the redemption of our public shares at varying levels and the exercise in full and no exercise of the over-allotment option. See "

Dilution

Dilution " for more information. As of July 28, 2025 Public Offering Price of $ 10.00 per Share 25% of Maximum Redemption 50% of Maximum Redemption 75% of Maximum Redemption Maximum Redemption NTBV NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price Assuming Full Exercise of Over-Allotment Option $ 6.58 $ 5.95

View Full Filing

View this S-1 filing on SEC EDGAR